XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 31, 2020
Nov. 02, 2019
Oct. 31, 2020
Nov. 02, 2019
Income Statement [Abstract]        
Net sales $ 109,025 $ 115,159 $ 329,374 $ 378,183
Cost of sales 68,211 73,573 206,711 251,578
Gross profit 40,814 41,586 122,663 126,605
Operating expense:        
Distribution and selling 31,490 38,332 97,100 128,717
General and administrative 4,687 5,415 15,158 17,816
Depreciation and amortization 7,977 2,053 16,700 6,234
Restructuring costs 55 1,516 264 6,681
Executive and management transition expense 0 87 0 2,428
Total operating expense 44,209 47,403 129,222 161,876
Operating loss (3,395) (5,817) (6,559) (35,271)
Other income (expense):        
Interest income 1 4 2 15
Interest expense (1,339) (914) (3,920) (2,608)
Total other expense, net (1,338) (910) (3,918) (2,593)
Loss before income taxes (4,733) (6,727) (10,477) (37,864)
Income tax provision (15) (14) (45) (44)
Net loss $ (4,748) $ (6,741) $ (10,522) $ (37,908)
Net loss per common share $ (0.39) $ (0.89) $ (1.05) $ (5.20)
Net loss per common share — assuming dilution $ (0.39) $ (0.89) $ (1.05) $ (5.20)
Weighted average number of common shares outstanding:        
Basic 12,177,990 7,577,028 10,000,383 7,286,380
Diluted 12,177,990 7,577,028 10,000,383 7,286,380